Summary In the present study we have confirmed that approximately one third of human colorectal carcinomas fail to express the HLA -A, B, C monomorphic determinant reactive with the W6/32 MAb, and 44% express class II HLA antigens as shown by reactivity with NFK-1 MAb. Reduced staining with the W6/32 MAb was not always associated with loss of ,B2m. In addition, the expression of HLA-A2 and Bw4 class I specific haplotypes on normal colon epithelium and tumour biopsy tissue was assessed. All normal colonic epithelia stained positively with MAb against A2 and Bw4 antigens, but a loss of these determinants was shown on tumour biopsies from patients tissue typed for the respective specificities. Loss of the A2 haplotype was shown in 4 of 15 tumour tissue samples, and loss of Bw4 specificities in 5 out of 7 tissue samples. The failure to detect specific loci determinants was not necessarily associated with loss of reactivity with W6/32 MAb.
Class I and class II MHC antigens are essential for the regulation of several immune functions. MHC class I antigens operate as restriction elements in T-cell mediated cytotoxicity, whilst class II antigens are involved in the presentation of antigen to cells of the immune system (Zinkernagel & Doherty, 1979; Benacerraf, 1981) . Studies on the expression of HLA antigens on tumour cells using conventional tissue typing techniques have indicated that altered expression of HLA antigens can occur (Pollack et al., 1980; 1981) . More recently, monoclonal antibodies against HLA-A, B or C framework structures and the associated beta-2 microglobulin (fl2m) have shown that a reduced expression, and in some cases a complete loss of class I antigens, is found in certain tumours (Fleming et al., 1981; Daar & Fabre, 1983; Csiba et al., 1984; Momberg et al., 1986) . Inappropriate expression of HLA class II antigens has been demonstrated in malignant melanoma, breast carcinoma and colorectal cancer (Natali et al., 1983; Brocker et al., 1984; Wilson et al., 1984; Daar & Fabre, 1983; Rognum et al., 1983) .
In a recent study Van den Ingh et al. (1987) failed to demonstrate a correlation between the histological characteristics of colorectal tumours and either the abnormal expression of class II antigens or the loss of class I antigens; adenomas and non-mucinous carcinomas were shown to strongly express class I framework antigens. It is perhaps significant that mucinous tumours, which have a poor prognosis, showed loss of expression of HLA-antigens and low numbers of infiltrating lymphocytes.
An additional study by Momberg et al. (1986) has suggested that the loss of class I antigens from the surface of colorectal tumour cells is related to a lower degree of differentiation. These tumours, like the mucinous tumours, have a poor prognosis which may indicate that loss of class I determinants is associated with a more malignant phenotype. Although definitive evidence for this has not yet been documented, experiments in murine models of tumour growth and metastasis suggest that loss of class I expression may influence tumour progression. Transfection of class I genes into tumours lacking expression was found to hinder tumour growth and in some cases abrogate metastasis (Hui et al., 1985; Wallich et al., 1985) . distant from the tumour, were collected from each patient, wrapped in aluminium foil, sprayed with 'Supra-freezit' (Sorrisol, Merseyside) and snap-frozen. All tissue samples were stored at -80°C until frozen sections were cut using a cryostat at a thickness of 5-1O0tm. A total of 30 patients were included in the study and the majority of these were tissue typed for HLA-A, B and C, using peripheral blood lymphocytes from the patient and conventional lymphocytotoxicity techniques (typing antisera and complement).
Immunoperoxidase staining of frozen sections Slides stored at -80°C were warmed to room temperature and rehydrated in Tris-buffered saline (TBS). Following the removal of excess TBS, 40,ul mouse monoclonal antibody (MAb) (at the appropriate dilution in TBS) was laid onto each section which was incubated for 40min in a humidified atmosphere at room temperature. The sections were then washed twice in TBS prior to the addition of 50,ul rabbit anti-mouse peroxidase (Dako Ltd., Bucks.). The slides were covered and left for 40min at room temperature and subsequently washed twice in TBS, flooded with diaminobenzidine (DAB) and with 0.5% (v/v) hydrogen peroxide for 10min. Following washing of the slides in tap water they were stained in Harris's haematoxylin and mounted for examination under a light microscope.
Monoclonal antibodies
The following monoclonal antibodies (MAbs) were used in the study: W6/32 directed against the monomorphic alpha chain determinant of HLA-A, B, and C framework antigens (Barnstable et al., 1978) , was a gift from Dr W.F. Bodmer, Imperial Cancer Research Fund, Lincoln's Inn Fields, London; anti-,B2m was purchased from Sera-tech Limited: NFK-1 monoclonal antibody (Daar et al., 1984) , which HLA typing at A and B loci was performed using a standard microlymphocytotoxicity assay with reagents specific for the following antigens: A1, 2, 3, 9, 25, 26: 11, 28, 29, w30, w31: B5, 7, 8, 44, 45, 13, 14, 15, 16, 17, 18, 21, 22, 27, 35, 37 WHO. (Table I) , whereas the tumour samples from these patients showed a variable staining pattern. Of the 7 tumours examined, 4 showed a partial loss of 116.5.28 reactivity and one a complete absence of detectable antigen. Three samples that showed negative staining with MAb 116.5.28, reacted in consecutive sections with MAb W6/32, indicating that although a monomorphic antigen sequence of HLA class I was present, the Bw4 specificity had been lost. Figure 1 shows an example of tumour stained uniformly with W6/32 MAb, but loss of reactivity with the BB7.2 MAb (anti-HLA-A2 specific). Of the tumours showing a loss of HLA-A2 specificity, 3 out of 4 were well differentiated whereas the majority of tumours showing no loss of antigenic expression were moderately differentiated (only 3 out of 11 were well differentiated). Within the group of 5 tumours showing a loss of HLA-Bw4 antigen specificity, 2 out of 5 were well differentiated (Table I) . Tumours showing a loss of polymorphic HLA determinants were classified mostly as Dukes' stage B (7 out of 9 tumours were Dukes' B), although no definite correlation could be established between loss of specificity and disease stage.
Discussion
Cytotoxicity by T lymphocytes towards neoplastic cells relies on the co-expression of specific antigenic determinants and class I histocompatibility antigens (Zinkernagel and Doherty, 1979) . Class I and II MHC antigens also have a role in the induction and modulation of immune reactivity, including the presentation of foreign antigens to class II restricted helper T lymphocytes and target cell recognition by class I restricted cytotoxic T lymphocytes. It is therefore important to determine the aberrant expression of MHC antigens in disease states, and many studies have shown that significant changes in both class I and class II HLA antigens occur in malignant disease (Fleming et al., 1981; Bhan and DesMarais, 1983; Whitwell et al., 1984; Rowe & Beverley, 1984; Daar & Fabre, 1983; Csiba et al., 1984; Umpleby et al., 1985; Momberg et al., 1986; Daar et al., 1982) .
Approximately one third of colorectal tumours show reduced staining with W6/32 MAb, which reacts with HLA-A, B, C framework determinants (Momberg et al., 1986) , and this finding shows a relationship with poorly differentiated tumours. Our results, showing a loss of W6/32 reactivity are consistent with previous reports.
The present study has also confirmed that class II HLA antigens are expressed in approximately one third of the tumours, and these results are similar to those reported by others (Daar et al., 1982; Daar & Fabre, 1983; Csiba et al., 1984) . Recently the distribution of the D-region sub-locus products in colorectal cancer has been reported (Ghosh et al., 1986) , where DR appeared as the prominent specificity, but the expression of DR, DP and DQ determinants failed to correlate with disease stage or degree of differentiation.
In previous reports MAbs have been used which showed specificity for non-polymorphic determinants of HLA class I molecules, where any loss of individual specificities of the HLA A or B locus would not have been detected. In the present study we have used two MAbs with specificity for the HLA-A2 and HLA-Bw4 determinants (Brodsky et al., 1979; Gelsthorpe, unpublished 
